Viatris (VTRS) Notes Payables (2020 - 2023)

Viatris' (VTRS) quarterly Notes Payables came in at $100000.0 in Q3 2023, down 99.98% year-on-year from $500.4 million in Q3 2022, and down 99.57% quarter-over-quarter from $23.2 million in Q2 2023.

Viatris (VTRS) Notes Payables (2020 - 2023) Analysis & Trends

Viatris' Notes Payables history runs 4 years deep, the most recent figure standing at $100000.0 for Q3 2023.

  • On a quarterly basis, Notes Payables fell 99.98% year-over-year to $100000.0 in Q3 2023; TTM through Sep 2023 was $100000.0, a 99.98% decrease from a year earlier, with the FY2021 full-year figure at $1.5 billion, up 35.34% from the prior year.
  • Notes Payables fell to $100000.0 in Q3 2023 per VTRS's latest filing, from $23.2 million in the prior quarter.
  • Across five years, Notes Payables topped out at $1.7 billion in Q3 2021 and bottomed at $100000.0 in Q3 2023.
  • The 4-year median for Notes Payables is $655.4 million (2022), against an average of $730.8 million.
  • Across the five-year window, Notes Payables surged 1676.15% in 2022 and slumped 99.98% in 2023, its largest moves.
  • Year by year, Notes Payables stood at $1.1 billion in 2020, then soared by 35.34% to $1.5 billion in 2021, then tumbled by 66.42% to $500.4 million in 2022, then slumped by 99.98% to $100000.0 in 2023.
  • Per Business Quant, the three latest VTRS Notes Payables figures stand at $100000.0 (Q3 2023), $23.2 million (Q2 2023), and $204.6 million (Q1 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Sep 30, 2023 100,000.00
Jun 30, 2023 23.20 Mn
Mar 31, 2023 204.60 Mn
Sep 30, 2022 500.40 Mn
Jun 30, 2022 1.02 Bn
Mar 31, 2022 655.40 Mn
Dec 31, 2021 1.49 Bn
Sep 30, 2021 1.71 Bn
Jun 30, 2021 1.30 Bn
Mar 31, 2021 36.90 Mn
Dec 31, 2020 1.10 Bn